The basic mechanism of mucoadhesion and methods to evaluate it in the context of pharmaceutical applications will also be reviewed, also how it can improve and differentiate drug products.

Drugmaker Mayne Pharma Group, which has lost 59 per cent ... to stay away from acquisitions and remain open to rustling up M&A.

Webcast to be held Thursday, November 7th, 4:30 p.m. ET, register for the webcast here, or at the link provided below. DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), an artificial ...

Bryn Pharma added Joshua Ziel as CEO. Incannex hired Lou Barbato as chief medical officer. DELFI Diagnostics named Robert Guigley as chief commercial officer. Manuel Frank joined Havas Life, a 2024 ...

Egypt - The Suez Canal Economic Zone (SCZone) is set to establish a dedicated pharmaceutical industrial zone covering 4 million square meters (sqm), SCZone's Head Waleid Gamal El-Dien announced during ...

As the U.K. works to pump fresh cash into the local biopharma scene, London’s Accord Healthcare is capitalizing on the government’s renewed willingness to chip in. Flush with a 50 million ...

A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell/File Photo The number of sexually transmitted ...

BOSTON (WWLP) – A former employee at a Massachusetts pharmaceutical company was sentenced to prison in connection with embezzling over $2.5 million. According to the Department of Justice ...

Chris Rose of ProStrakan offers advice on selling in the pharmaceutical industry ... Is there a simple "7 step model" for buying? I'm not sure but let me see if I can create one!

Data from the second annual MM+M/Publicis Health Pharma Marketing Transformation Survey backs up what industry leaders told MM+M. Just 39% say new ways of harnessing advanced tools such as AI and ...

What is Pharma 4.0? The term Industry 4.0 refers to the fourth industrial revolution, associated with the application of advanced technologies that have dramatically changed the landscape of ...

The pharmaceutical value chain model depicted in Figure 1 covers a full range of activities that are required to bring a product from conception to final consumer. The key players in the chain are ...